Interface Biosciences (Seed)

Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Funding URL
View Funding Page
Valuation
$12,500,000

Company Info
Founders
Hannah Wastyk
Company Description
AI-enabled, metabolomics-based drug discovery engine for inflammatory disease. Interface Biosciences is a platform therapeutics company that specializes in using the microbiome to treat inflammatory diseases.
Market
Healthcare & Wellness
Coinvestors
Ulu Ventures,Pear VC

Links
Back to Home Back to Healthcare and Biotech Deals View Funding Announcement